Connecting leaders to solve digital health challenges



Get insight for DTx routes to market for pharma, direct to consumer and alternative options in our latest report.

Download your exclusive free snapshot of our latest industry report on Digital Therapeutics - Routes To Market - Part 2 now.

HealthXL Members can access the full report now, exclusively from our platform.

Download your free snapshot of the report

To Market: Part 2

About This Report

While significant advancements have been made in the field of digital therapeutics over the last number of years, implementing a successful go-to-market strategy remains a key challenge. We see a lot of trial and error, and migration between commercialisation pathways. There is no silver bullet, yet.

The Challenge

Our Goal

In this report we examine potential routes-to-market for digital therapeutics and provide our insights on how we believe each of these avenues will likely develop, which one you should choose, when and why. The report is peppered with inputs from the HealthXL DTx community too.
The routes to market for digital therapeutics that are covered in this report include pharma, direct-to-consumer and alternative options.

Why Now?

2018: The industry was only just familiarising itself with these novel solutions and we launched our first industry report exploring what exactly a digital therapeutic is.

2021: We started to see a unique opportunity emerge within this space for prescription digital therapeutics (PDT), and we released our second report in this series exploring PDTs in detail.

Now, the time has come to understand how exactly all of this translates into commercially viable businesses.

The digital therapeutics market is evolving rapidly.

What digital health leaders say

“The HealthXL Digital Therapeutics: Routes to Market Report is a great resource for anyone interested in learning more about the many ways in which DTx are reaching the end-user. The report gives a comprehensive overview of the main market entry routes while also offering insight and perspective on which are best suited to prospective solutions based on a variety of factors.”

Robert Garber, Partner, 7Wire Ventures

HealthXL is trusted by:

© 2021 HealthXL All rights reserved.

Miss part 1 of our report? Get it now

Current Approaches to Commercialisation

 Routes to Market 1: The Employer

Interested in accessing the full 60-page report? Book a call with our team now to learn more about the great benefits of being a HealthXL member

Focus of Part 1

Schedule a call

The full report is available now exclusively for HealthXL members

Get your free copy now